Affordable Access

Publisher Website

Molecular genotyping of hepatitis B virus

Authors
Journal
Journal of Clinical Virology
1386-6532
Publisher
Elsevier
Publication Date
Volume
25
Identifiers
DOI: 10.1016/s1386-6532(02)00193-2
Keywords
  • Hepatitis B Virus
  • Chronic Infection
  • Therapy
  • Lamivudine
  • Resistance
  • Genotyping
Disciplines
  • Biology
  • Medicine

Abstract

Abstract The development of new therapeutic agents against hepatitis B virus (HBV) and the predictable emergence of resistant mutants have highlighted the need to provide new molecular assays for optimal therapeutic management. Similarly, other variants and genotypes of HBV have now been identified that appear to have distinct clinical and pathological importance. This paper outlines the current clinical importance of HBV on a global scale, reviews the current generation of molecular genotyping assays and discusses the prospects for new assays in the near future.

There are no comments yet on this publication. Be the first to share your thoughts.